These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Statins in the medical management of postoperative coronary artery bypass. Alexander JC Chest; 2005 Feb; 127(2):423-4. PubMed ID: 15705974 [No Abstract] [Full Text] [Related]
3. Frontiers in Lipid Lowering Therapy: To Statins and Beyond. Chaudhuri A Eur J Vasc Endovasc Surg; 2020 Dec; 60(6):798-799. PubMed ID: 33004279 [No Abstract] [Full Text] [Related]
4. Lipid lowering beyond statins and methodological issues in cardiovascular clinical trials. Crea F Eur Heart J; 2022 Apr; 43(14):1365-1368. PubMed ID: 35388411 [No Abstract] [Full Text] [Related]
5. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Hunninghake DB Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501 [TBL] [Abstract][Full Text] [Related]
7. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond. Margaritis M; Antoniades C Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521 [No Abstract] [Full Text] [Related]
8. Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart disease. Mayor S BMJ; 2016 Jun; 353():i3437. PubMed ID: 27335335 [No Abstract] [Full Text] [Related]
9. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Kulik A; Ruel M Curr Opin Cardiol; 2011 Nov; 26(6):508-17. PubMed ID: 21934497 [TBL] [Abstract][Full Text] [Related]
10. Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies? Frishman WH Am J Med; 2015 Nov; 128(11):1160-1. PubMed ID: 26184685 [No Abstract] [Full Text] [Related]
11. Aggressive lipid-lowering therapy and regression of coronary atheroma. Ravnskov U; Sutter MC JAMA; 2004 Jul; 292(1):38; author reply 39-40. PubMed ID: 15238580 [No Abstract] [Full Text] [Related]
19. Statins for all patients with type 2 diabetes: not so soon. Garg A Lancet; 2004 Aug 21-27; 364(9435):641-2. PubMed ID: 15325810 [No Abstract] [Full Text] [Related]
20. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?]. Müller-Wieland D; Faust M; Schleifenbaum T; Krone W MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]